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ABSTRACT
Background Cognitive impairment and dementia are
common after stroke. It is unclear if risk differs between
ischaemic stroke subtypes. Lacunar strokes might be less
likely to affect cognition than more severe, larger cortical
strokes, except that lacunar strokes are associated with
cerebral small vessel disease (SVD), which is the
commonest vascular cause of dementia.
Methods We searched MEDLINE and PsychINFO for
studies of mild cognitive impairment (MCI) or dementia
after lacunar or cortical ischaemic stroke. We calculated
the OR for cognitive impairment/dementia in lacunar
versus non-lacunar stroke, and their incidence and
prevalence in lacunar stroke as a pooled proportion.
Findings We identiﬁed 24 relevant studies of 7575
patients, including 2860 with lacunar stroke; 24% had
MCI or dementia post stroke. Similar proportions of
patients with lacunar and non-lacunar stroke (16 studies,
n=6478) had MCI or dementia up to 4 years after stroke
(OR 0.72 (95% CI 0.43 to 1.20)). The prevalence of
dementia after lacunar stroke (six studies, n=1421) was
20% (95% CI 9 to 33) and the incidence of MCI or
dementia (four studies, n=275) was 37% (95% CI 23
to 53). Data were limited by short follow-up, subtype
classiﬁcation methods and confounding.
Interpretation Cognitive impairment appears to be
common after lacunar strokes despite their small size,
suggesting that associated SVD may increase their
impact. New prospective studies are required with
accurate stroke subtyping to assess long term outcomes
while accounting for confounders.
INTRODUCTION
Dementia is common soon after stroke1 but we
know little of the mechanisms or whether the risk
varies with stroke subtype. Stroke risk factors,
amounts and regions of the brain affected, and
suggested stroke mechanisms all vary with stroke
subtype, and could inﬂuence the risk of cognitive
impairment after stroke. For example, as cortical
ischaemic strokes often affect a large area of brain,
they may carry a higher risk of cognitive impair-
ment than the smaller, less neurologically severe,
lacunar strokes. Alternatively, lacunar strokes may
carry a higher risk of cognitive impairment than
would be expected on the basis of the lacunar
infarct alone as they are part of the spectrum of
cerebral small vessel disease (SVD). SVD, which
affects the brain diffusely and is the commonest
vascular cause of cognitive impairment,2 could be
unmasked by a new lacunar stroke. A recent
systematic review3 included studies of patients after
lacunar stroke who had undergone detailed neuro-
psychological assessments but did not provide
information on whether lacunar stroke patients are
at greater risk than other stroke subtypes, or on
potential confounding factors.
We sought to establish the incidence and preva-
lence of cognitive impairment and dementia after
lacunar stroke, in the short and long term, and its
magnitude in comparison with cortical stroke, by
systematically reviewing the available literature. We
also aimed to evaluate study quality and whether
they had accounted for confounding factors that
may affect performance on cognitive tests such as
depression, lower premorbid IQ and pre-existing
dementia or SVD.
METHODS
Search methods
Following guidance from experienced librarians
from the Cochrane Stroke Group, we searched
MEDLINE (1991 to present) and PsychINFO (1991
to present) with the terms (a) ‘cognition’ ‘dementia’
‘vascular dementia’ or ‘multi-infarct dementia’ and
(b) ‘stroke’ or ‘lacunar stroke’ (last searched 7 June
2012, using OVID SP V.03.07.00.119, details in the
online supplementary information). We checked
references in review articles and hand searched the
previous 5 years of Stroke and Age and Aging. We
complied with the meta-analysis of observational
systematic reviews (MOOSE)4 group guidelines.
Study criteria
In our primary analysis we included studies that
compared cognition in patients with lacunar stroke
with those with cortical stroke. Our secondary ana-
lysis to determine the incidence and prevalence of
mild cognitive impairment (MCI) and dementia
analysed all studies that measured cognition in
patients with lacunar stroke.
We included studies that assessed MCI and
dementia in adult humans with symptomatic
lacunar stroke (deﬁned below). We excluded studies
of asymptomatic patients with lesions on imaging
and autopsy studies.
In order to establish the proportion of lacunar
stroke patients with MCI or dementia, we included
studies that tested an unselected group of patients.
We excluded studies that tested a very selected
group of patients—for example, a study of only
patients with a particular radiological ﬁnding such
as a recent lacunar infarct in the thalamus.
Open Access
Scan to access more
free content
Makin SDJ, et al. J Neurol Neurosurg Psychiatry 2013;84:893–900. doi:10.1136/jnnp-2012-303645 893
Cerebrovascular disease
To cite: Makin SDJ,
Turpin S, Dennis MS, et al. J
Neurol Neurosurg Psychiatry
2013;84:893–900.
Protected by copyright.
 o
n
 Septem
ber 19, 2019 at University of Aberdeen.
http://jnnp.bmj.com/
J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp-2012-303645 on 1 March 2013. Downloaded from 
We included English and non-English language studies. We
excluded studies that were published only in abstract and those
which had tested a group of stroke patients, including some
with lacunar stroke, but not presented the results according to
stroke subtype.
Deﬁnitions of lacunar stroke, dementia and MCI
We set the reference standard for stroke subtyping as a non-risk
factor dependent clinically based approach (such as the
Oxfordshire Community Stroke Project, OSCP)5 accompanied
by MRI, including diffusion weighted imaging (DWI), to iden-
tify the recent acute ischaemic lesion. We also accepted studies
which made the diagnosis of stroke subtype in other ways, such
as clinical syndrome plus CT scanning instead of MR with DWI.
We deﬁned a lacunar stroke as one diagnosed as ‘lacunar’ on
clinical grounds (a typical lacunar syndrome, or using methods
devised by Bamford et al5 in the OCSP or similar method) with
or without imaging veriﬁcation, or as a clinically evident stroke
classed as ‘small vessel’ by the risk factor based classiﬁcations
such as the Trial of ORG 10172 in Acute Stroke Treatment
(TOAST) classiﬁcation.6 We deﬁned non-lacunar stroke as a
sudden onset of neurological symptoms classed as ‘cortical
stroke’ clinically with or without imaging veriﬁcation, or a
stroke classed as ‘large artery atherosclerosis’, ‘cardioembolism’,
‘cryptogenic’ or ‘other’ on TOAST, or other risk factor based
classiﬁcations.6 We noted the deﬁnition used in each study so as
to perform sensitivity analyses.
We set the reference standard for cognitive impairment
as a full neuropsychological assessment covering all cognitive
domains, blinded to stroke subtype. We deﬁned dementia as
impairment of cognitive function which interfered with every-
day activities, and we deﬁned MCI as impairment of cognitive
function not severe enough to interfere with everyday life.7 We
used the term ‘cognitive impairment’ to refer to any impairment
of cognitive function whether MCI or dementia.
We included studies which had made the diagnosis of cogni-
tive impairment or dementia in other ways, such as the
Mini-Mental State Examination (MMSE). We used the criteria
for cognitive impairment, MCI or dementia as applied in indi-
vidual studies.
Data extraction
We used a pretested form to extract available data. We extracted
the following data about patient recruitment and assessment
methods: inclusion and exclusion criteria (speciﬁcally whether
the study included patients with prior stroke, prior cognitive
impairment or aphasia, and if so whether adapted tests were
used); how stroke subtypes were deﬁned and if there were any
differences between the subtypes; whether information was
sought from relatives about signs of cognitive decline prior to
stroke; and the details of assessments, including whether depres-
sion or premorbid IQ were measured and accounted for, what
proportion of patients were able to complete cognitive testing
and whether the cognitive assessors were blinded to the clinical
information. We extracted the details about the study popula-
tion: ages and risk factors; number of patients with lacunar or
non-lacunar stroke and how many were recorded as having
dementia and/or MCI; if impairments occurred in any particular
cognitive domain; and any calculated odds or HRs and whether
these were adjusted for risk factors, including SVD on imaging,
depression and premorbid IQ.
If a study had published more than one paper, we ensured
that each patient only contributed once towards the present ana-
lysis. The studies were reviewed and the data extracted by two
of the authors (SDJM and ST) with advice from another author
( JMW). We did not contact the authors to obtain additional
information.
Statistical analysis
Firstly we investigated whether patients with lacunar stroke
were more likely to have cognitive impairment than patients
with non-lacunar stroke by calculating the pooled OR and 95%
CI of cognitive impairment in patients with lacunar compared
with cortical stroke (the OR would be >1.0 if cognitive impair-
ment were more common in lacunar stroke).
We examined the impact of potential confounders by record-
ing available adjusted outcome measures and by analysis of the
following prespeciﬁed subgroups: community versus hospital
based studies; timing of cognitive assessment after stroke (ear-
ly=under 1 month, mid=1 month to 1 year and later than
1 year); whether or not patients with previous stroke and/or
dementia had been excluded; stroke subtyping method used; cog-
nitive test used; whether depression or premorbid IQ were
accounted for; whether patients had MRI or CT imaging to aid
diagnosis of subtype; and the proportion of patients who were
cognitively assessed. Secondly, we aimed to calculate the inci-
dence and prevalence of cognitive impairment and dementia
after lacunar stroke. We calculated the OR and 95% CI using a
weighted Mantel–Haenszel summary OR in Review Manager
V.5.1. We calculated the incidence and prevalence of cognitive
impairment and dementia in patients with lacunar stroke as a
pooled proportion and 95% CI, using a DerSimonian Laird
random effects model in StatsDirect V.2.7.8. We assessed for het-
erogeneity by calculating the I2 statistic for each meta-analysis
and publication bias using a funnel plot. We used a random
effects model due to potential heterogeneity in the underlying
methodology. No ethics approval was necessary in order to
conduct this literature review as it was all literature based.
RESULTS
Of 320 potentially suitable papers, 164 assessed cognition in
stroke patients but only 57 assessed both cognitive function and
stroke subtype; of these, 33 presented the results by subtype but
nine did not meet other prespeciﬁed criteria (see details in the
online supplementary table), leaving 24 that met our inclusion
criteria (ﬁgure 1). The 24 studies included 7575 subjects with
ischaemic stroke (table 1).
Nineteen studies compared lacunar with non-lacunar
stroke9–29 35 36 (79% of studies, 95% of subjects), three
studies30 32 33 compared lacunar stroke with healthy volunteers
and two had no control group. Median study size was 170
patients (range 30–3201) and mean age of the patients was
73 years (we were not able to calculate median age).
Assessment of cognition, potential confounders and reporting
of results varied. Seventeen studies9–17 19–25 27 29 30 35 36
reported the number of subjects in whom testing was attempted
(9154 patients) and the number that completed the tests (7401
patients); eight9–12 14 16 17 24 27 36 studies reported the com-
bined number of attempted and successful tests in patients with
ischaemic and haemorrhagic stroke, but not the values for
ischaemic stroke alone; and seven studies18 25 26 29 31 34 35
reported cognitive outcomes for 155 patients who only com-
pleted some of the assessments. Two studies 12 30 excluded
patients with depression (8% of studies, 2% of patients); one
study10 measured premorbid IQ using the National Adult
Reading Test but did not account for it in the analysis (4% of
studies, 3% of patients); and nine studies9–11 15 18 24 26 27 30
interviewed relatives about signs of cognitive decline prior to
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the index stroke (38% of studies, 19% of patients). Three
studies9 24 25 stated that the assessors were blinded to the stroke
subtype (13% of studies, 7% of patients) but the rest did not
mention blinding. Some information on background SVD was
obtained in 10 studies but the varied methods and reporting
precluded its further use: one study (n=81) measured white
matter lesion (WML) volume on MRI in all patients;31 another
(n=170) measured WML volume in 133/170 patients who had
MRI10; and eight studies11 12 18 21 24 26 30 33 scored leukoaraio-
sis on CT scans of all patients (33% of studies, 16% of patients).
Stroke subtyping methods and use of imaging in subtype diag-
nosis varied. All studies required a clinical diagnosis of a stroke
alongside imaging to exclude haemorrhage. Two studies23 31
performed MRI on all patients but did not state whether
or not this included DWI (8% of studies, 5% of patients), a
further 1111–13 18 24 26 28 30 33 34 36 performed CT scanning on
all patients (46% of studies, 28% of subjects). The remaining
studies either performed a mixture of CT and MRI scans or did
not give imaging details. Nine studies12 16 26 29 31 32 28 33 35
used a risk factor free clinical classiﬁcation (eg, OCSP5) to cat-
egorise subjects as ‘lacunar’ or ‘non-lacunar’ stroke (38% of
studies, 23% of patients). Nine studies10 13–15 18 23 27 34 36 used
the risk factor based TOAST classiﬁcation (38% of studies, 66%
of patients). Six studies9 11 20 24 25 30 used imaging features
alone to subtype the clinically apparent stroke (25% of studies,
11% of patients).
The extent of cognitive testing varied. Sixteen
studies9–12 14 15 18 21 23 25–28 32 34 35 performed detailed cogni-
tive testing of all cognitive domains (67% of studies, 72% of
patients). Six studies16 24 29 31 33 36 used only the MMSE (25%
of studies, 18% of patients). One11 (n=58) used the Rotterdam
Cambridge Cognitive Assessment (R-CAMCOG) while
another30 (n=75) used the Alzheimer’s Disease Assessment
Scale cognitive subscale (ADAS-COG) and MMSE. One study13
(n=726) based cognitive assessment on the assessing clinician’s
impression of whether the patient was demented. Two
studies10 20 recorded the number of subjects with MCI but no
dementia. One study35 (n=336) reported test results across
OCSP subtypes: lacunar patients performed worse on the
‘matrix reasoning’ test of visuoperceptual functioning and anter-
ior (not posterior) circulation cortical stroke patients performed
worse on the Stroop test of executive function; neither differ-
ence was seen on other tests of the same function.
The timing of the cognitive assessment varied. Four
studies9 14 29 34 assessed cognition in the ﬁrst month after stroke
(17% of studies, 42% of patients). Twelve studies10–12 15 16 23–28 30
assessed cognition between 3 months and 1 year (50% studies,
34% patients), and eight13 18 20 31–33 35 36 assessed cognition
between 1 and 4 years after stroke (33% studies, 24% patients).
We compared the risk of cognitive impairment in patients
with lacunar stroke with those with non-lacunar stroke
(ﬁgure 2). As we were not able to analyse studies that only pre-
sented mean cognitive test scores nor those without a control
group, only 16/24 studies9–16 18 22–28 of 6478 subjects contribu-
ted to this analysis. The proportion of patients with cognitive
impairment—either MCI or dementia—did not differ between
patients with lacunar and non-lacunar stroke: 638/2222 (29%)
subjects with lacunar stroke compared with 1001/4256 (24%)
subjects with non-lacunar stroke (OR 0.72; 95% CI 0.43 to
1.20). The substantial heterogeneity between the studies
(I2 91%; p=0.00001) was not apparently due to publication
bias (ﬁgure 3) or to differences in the time elapsed between the
index stroke and assessment of cognition (ﬁgure 2).
We performed a sensitivity analyses (ﬁgure 4) by sequentially
excluding studies with particular characteristics and then
repeating the analysis. Among hospital based studies, cognitive
impairment was more common in non-lacunar stroke (OR
0.67; 95% CI 0.51 to 0.86); in community based studies,
cognitive impairment was more common in lacunar stroke
(OR 1.56; 95% CI 0.32 to 7.64) but with considerable hetero-
geneity (I2 98%; p<0.001). There was little difference in the
summary OR between studies that only included ﬁrst stroke
Figure 1 Flow diagram of search strategy and results.
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Table 1 Characteristics of included studies
Reference Setting
Total patients
consented/total tested
Timing of tests
post-stroke Test done Subtyping
Primary
outcome Results
Nys 20078 9 Hospital
The Netherlands
190/168* 3 weeks NP† Imaging MCI‡ 29/64 (45%)§ Lacunar
47/63 (75%)§ Non-lacunar
Sachdev et al10 Hospital Australia 210/170* 3–6 months NP Risk factor Dementia or
MCI
24/46 (52%) Lacunar
74/120 (62%) Non-lacunar
De Koning et al11 Hospital
The Netherlands
130/121* 3–9 months NP Imaging Dementia 4/20 (20%) Lacunar¶
17/38 (45%) Non-lacunar¶
Censori et al12 Hospital Italy 121/110** 3–4 Months NP and MMSE†† Clinical Dementia 2/21 (10%) Lacunar
13/83 (16%)Non-lacunar
Tatemichi et al13 Hospital USA 927/726 2 years Clinical impression Risk factor Dementia 25/227 (11%) Lacunar
91/499 (18%) Non-lacunar
Bejot et al14 Community France 3948/3201* 1 month NP Risk factor Dementia 333/887 (38%) Lacunar
289/1960 (15%)
Non-lacunar
Lin et al15 Hospital Taiwan 353/283 3 months NP Risk factor Dementia 13/136 (10%) Lacunar
13/147 (9%) Non-lacunar
Patel et al16 17 Community UK 1454/654* 3 months MMSE Clinical MMSE<24 72/218 (33%) Lacunar
124/297 (42%)
Non-lacunar
Cordoliani-Mackowiak
et al18
Hospital France 132/88‡‡ Up to 3 years NP Risk factor Dementia 8/31 (26%) Lacunar
24/101 (24%) Non-lacunar
Rasquin et al
19–22
Hospital The
Netherlands
176/144 1 years NP Imaging MCI or
Dementia
40/57 (70%) Lacunar
59/87 (68%) Non-lacunar§§
Pohjasvaara et al23 Hospital Finland 451/337 3 months NP Risk factor Dementia 5/21 (24%) Lacunar
102/316 (32%)
Non-lacunar
Tang et al24 Hospital China 484/280* 3 months MMSE Imaging Dementia 33/166 (20%) Lacunar
18/90 (20%) Non-lacunar
Madureira et al25 Hospital Portugal 180/165 3 months NP Imaging Dementia 6/139 (4.3%) Lacunar¶¶
5/41 (12%) Non-lacunar¶¶
Klimkowicz-Mrowiec
et al26
Hospital Poland 173/145‡‡* 3 months NP and MMSE Clnical Dementia 2/24 (8%) Lacunar
35/149 (23%) Non-lacunar
Dong et al27 Hospital Singapore 300/239* 3–6 months NP, MMSE, and
MoCA§§
Risk factor Moderate MCI 21/106 (20%) Lacunar
31/97 (33%) Non-lacunar
Tatemichi et al28 Hospital USA Not stated/227 3 months NP Clinical MCI 21/59 (36%) Lacunar
59/168 (35%) Non-lacunar
Tay et al29 Hospital Singapore 216/169 9 days MMSE Clinical NA Mean MMSE
Non-lacunar (anterior
circulation)18.2,
Lacunar 22.9
Mok et al30 Hospital China 86/75 3 months*** MMSE and clinical
dementia rating scale
Imaging Dementia 10/75 (13%)
Mean MMSE: 24.8 lacunar,
27.7 healthy controls
Samuelsson et al31 Hospital Sweden 100/81 2 years MMSE and NP if
impaired.
Clinical Dementia 8/81 (10%)
Anderson et al32 Community
Australia
Not stated/30 1 year NP Clinical MCI 2/30 (7%)
Loeb et al33 Hospital Italy Not stated/108 Up to 4 years MMSE Clinical Dementia 25/108 (23%)
Fure et al34 Hospital Norway 71/64‡‡ 2–7 days NP Risk factor MCI 41/71 (58%)
Barker-Collo et al35 Community New
Zealand
357/336 5 years NP Clinical Cognition test
results.
No difference in mean test
scores
Appelros et al36 Community
Sweden
253/232* 1 year MMSE Risk factor Mean MMSE
scores
Mean MMSE
Non-lacunar 25.6, Lacunar
26.6
*Includes subjects with haemorrhagic stroke/transient ischaemic attack.
†Full neuropsychological (NP) testing.
‡Mild cognitive impairment.
§14 haemorrhagic strokes included in these figures.
¶Subtype reported only in patients who had a visible lesion on CT.
**Six subjects with specific cognitive impairment excluded.
††Mini-Mental State Examination.
‡‡Data reported on subjects who could not have full tests.
§§Calculated from reported OR.
¶¶Calculated from χ2 statistic.
***The 61 non-demented patients were followed up 2–3 years later; no information on outcome of those who did have dementia at 3 months.37
§§MoCA, Montreal Cognitive Assessment.
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(OR 0.88; 95% CI 0.3 to 2.58), ﬁrst or recurrent stroke (OR
0.69; 95% CI 0.54 to 0.9), where subjects with prior dementia
were excluded (OR 0.63; 95% CI 43 to 0.91) or included (OR
0.88; 95% CI 0.35 to 2.55), between studies that tested
smaller or larger numbers of participants (OR 0.63; 95% CI
0.46 to 0.86), for studies testing <80% (OR 0.63; 95% CI
0.46 to 0.86) against studies testing >80% of patients (OR
0.72; 95% CI 0.33 to 1.57), or according to patient age,
whether limited or full neuropsychological testing was per-
formed, or by the proportion of patients who had MRI scan-
ning. Additionally, there was little difference in the summary
OR between studies that used clinical, imaging or risk factor
based subtyping to diagnosis lacunar stroke (see online
supplementary ﬁgure). We did not have enough information to
Figure 2 Odds of cognitive impairment in lacunar stroke versus cortical stroke.
Figure 3 Funnel plot demonstrating
that the heterogeneity was not due to
publication bias. This ﬁgure is only
reproduced in colour in the online
version.
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assess the impact of SVD on imaging. No studies provided a
multivariant analysis of the risk of cognition in lacunar stroke
adjusted for imaging evidence of SVD, depression, age or other
confounders.
Heterogeneity was due to one large study14 (n=2847) in
which cognitive impairment was more common in lacunar
stroke (OR 3.48, 95% CI 2.89 to 4.18). When the meta-analysis
was repeated after omitting this study, the OR changed from
0.72 (95% CI 0.43 to 1.20) with signiﬁcant heterogeneity
(as above) to 0.67 (95% CI 0.54 to 0.84) without signiﬁcant
heterogeneity (I2 26%, p=0.17).
For the second meta-analysis, we aimed to establish the inci-
dence and prevalence of cognitive impairment and dementia
after a lacunar stroke. We included data from all studies that had
measured cognition in patients with a lacunar stroke (a total of
21 studies of 2606 lacunar strokes) whether or not there was a
control group. We were not able to include those studies that
reported only average cognitive test results and did not dichot-
omise patients into ‘impaired’ and ‘not impaired’. A pooled pro-
portion of eight9 10 20 27 28 32–34 studies of 541 patients found
that 38% (95% CI 24 to 52, I2 92%) had MCI or dementia at
any stage after a ﬁrst or recurrent lacunar stroke. Fifteen studies
provided data on dementia at any time after lacunar stroke
(16%, 95% CI 10 to 24, I2 93.8%)10–16 18 22–26 30 31
We then calculated the incidence (table 2) of dementia or
MCI from studies that excluded patients with these conditions
prior to stroke. One small study12 (n=21) found that the inci-
dence of dementia was 10% (2/21; 95% CI 2 to 30) after a ﬁrst
lacunar stroke and another study10 (n=46) found that the inci-
dence of MCI was 34% (16/46; 95% CI 22 to 49). Six
studies10 12 15 18 25 26 (n=397) found that the incidence of
dementia after a ﬁrst or recurrent lacunar stroke was 12% (95%
CI 6 to 18). No studies of ﬁrst and recurrent lacunar stroke
recorded the incidence of MCI alone.
We planned to calculate the prevalence of dementia or
MCI from studies that had included patients who had these
conditions prior to the index stroke but no studies did this
for MCI. Six studies provided these data for patients with
dementia, two14 31 (n=987) for ﬁrst stroke (pooled percentage
21%; 95% CI 10 to 55) and six11 13 14 23 24 31 (n=1421)
for ﬁrst or recurrent lacunar stroke (pooled percentage 20%;
95% CI 9 to 33).
DISCUSSION
The available literature suggests that approximately 30% of
patients will be cognitively impaired in the 4 years following a
lacunar stroke, a similar proportion to non-lacunar stroke
(23%). However, precision and reliability of the estimate were
Figure 4 Sensitivity analysis: OR of cognitive impairment in lacunar against cortical stroke for studies with particular characteristics.
898 Makin SDJ, et al. J Neurol Neurosurg Psychiatry 2013;84:893–900. doi:10.1136/jnnp-2012-303645
Cerebrovascular disease
Protected by copyright.
 o
n
 Septem
ber 19, 2019 at University of Aberdeen.
http://jnnp.bmj.com/
J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp-2012-303645 on 1 March 2013. Downloaded from 
hampered by several factors. Thus despite SVD being the com-
monest vascular cause of cognitive impairment and lacunar
stroke often affecting people in middle not just old age, data to
calculate the true incidence or prevalence of cognitive impair-
ment after lacunar stroke and associated risk factors in order to
advise patients and plan services are lacking.
A recent review3 summarised domain speciﬁc cognitive
impairment after lacunar stroke but did not provide information
on the proportion of lacunar stroke patients who are cognitively
impaired, nor on whether this differs from non-lacunar stroke,
or on the outcome of patients who were not able to have
detailed cognitive assessment, nor the effect of depression, pre-
morbid IQ or imaging evidence of SVD. However, it did high-
light that when impairment does occur, it is generalised rather
than domain speciﬁc.
The limitations of the literature included the fact that many
studies were small, few assessors were blinded to the stroke
subtype, most studies did not account for important confoun-
ders, and the diagnostic methods and reporting varied consider-
ably. Importantly, there were few data on cognition beyond
1 year after the index stroke, yet lacunar stroke commonly
affects patients in their 50s and 60s with many years of life and
employment ahead. One study of 10833 patients performed
follow-up as late as 4 years, another35 assessed cognitive func-
tion up to 5 years but reported only the mean test scores, not
the number of patients with MCI or dementia. No studies used
the reference standard method to diagnose lacunar stroke and
differentiate it from non-lacunar stroke (risk factor free clinical
subtyping supported by MRI–DWI in the acute phase). We
could not perform risk factor adjusted analysis due to lack of
data. Potential confounding factors were poorly addressed: two
studies accounted for depression,12 30 only one10 measured pre-
morbid IQ (although 10 assessed for signs of pre-stroke cogni-
tive impairment) and data were inadequate to assess the effect
of background white matter hyperintensities. Most studies were
hospital based, but as lacunar stroke may be mild, not all cases
are admitted to hospital. Our calculations of incidence and
prevalence were hampered by many studies not reporting
whether the included patients had cognitive impairment or
dementia prior to the stroke.
The estimate of cognitive impairment after lacunar versus
non-lacunar stroke was strongly inﬂuenced by one study14 in
which dementia was much more common in lacunar than in
non-lacunar stroke (OR 3.48 vs OR 0.67 in all other studies
combined). We should not discount the ﬁndings of this large
population based study that contained 38% of all patients.
However, we noted two problems: cognition was assessed less
than 1 month after stroke and the OR of cognitive impairment
in lacunar stroke changed over the study period, from 10.1 in
1991–1996 to 1.51 in 2003–2008, implying a change in meth-
odology over time.
Our study has limitations. We lacked the resources to contact
the authors to obtain original patient data on risk factors or
missing values. However, it appeared that most of the missing
information had not been collected.
This study’s strengths include a comprehensive literature
review amassing data relating to 2860 lacunar stroke patients and
4275 non-lacunar controls, including studies published in Asia,
Europe and America. We did not exclude any studies because we
could not obtain the papers or translate them into English.
There is no ideal way of assessing cognition after stroke. Many
disabled patients will not be able to comply with detailed neuro-
psychological testing, yet a screening test may miss subtle cognitive
decline and dementia. Other factors apart from dementia and
MCI may affect cognitive assessment after stroke such as depres-
sion and fatigue; lacunar stroke is related to cerebral SVD which is
associated with late life depression.38 An apparent association
between dementia and lacunar stroke may be related to undiag-
nosed pre-stroke cognitive impairment or the stroke unmasking
the presence of SVD. Few studies accounted for depression, pre-
morbid IQ, pre-stroke cognitive decline, quantiﬁed WML or pre-
sented their data on cognition by WML load, so we were unable
to assess whether the cognitive impairment could be explained by
other factors. An apparent association between lacunar stroke and
cognitive impairment may be due to survivorship bias as patients
with a (often more severe) cortical stroke are less likely to survive
the acute post-stroke period.
There is a lack of information on long term prognosis yet the
chances of continuing cognitive decline after lacunar stroke may
be higher than in non-lacunar stroke due to the differences in
Table 2 Studies assessing incidence and prevalence of dementia and mild cognitive impairment in patients with lacunar stroke
No of studies No of patients Pooled risk or proportion (95% CI) (%) I2 (95% CI) (%)
Incidence of dementia (only previously non-demented patients included)
1st stroke 1 21 10 (2 to 27) n/a
1st or recurrent stroke 6 397 12 (6 to 18) 66.4 (0 to 89)
Prevalence of dementia (where the authors specified that they included patients who had dementia prior to the stroke)
1st stroke 2 987 21 (1 to 55) n/a
1st or recurrent stroke 6 1421 20 (9 to 33) 95.6 (93.4 to 96.8)
Prevalence of dementia (including studies where the methods were unclear and the authors did not state whether they included patients with dementia)
1st stroke 4 1262 20 (8 to 36) 95.9 (93 to 97)
1st or recurrent stroke 9 1777 18 (9.6 to 30) 95.7 (95 to 96.7)
Incidence of MCI or dementia (only previously cognitively intact patients included)
1st stroke 1 64 45 (34 to 58) n/a
1st or recurrent stroke 4 275 37 (23 to 53) 85.5 (54 to 93)
Prevalence of MCI or dementia (where the authors specifically included prior dementia and MCI)
No studies
Prevalence of MCI or dementia (including studies where the methods were unclear)
1st stroke 2 120 34 (0 to 9) n/a
1st or recurrent stroke 4 266 38 (13 to 66) 96 (93.3 to 97.3)
MCI, mild cognitive impairment.
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underlying pathology: SVD affects the brain diffusely whereas
non-lacunar stroke often has an extracranial cause. The progno-
sis is important to patients who are cognitively impaired after
lacunar stroke who wish to know if they will recover, to plan
stroke services and to enable the planning of sample size and
length of follow-up in future interventional studies.
Future research should focus on previously cognitively intact
patients with a ﬁrst lacunar stroke, extend follow-up for as long
as practicable, subtype the stroke on clinical grounds aided by
early MRI–DWI, account for confounding factors including dif-
ferences in vascular risk factors, premorbid IQ, pre-stroke cogni-
tive decline and depression, and validated imaging biomarkers
of SVD. Analysis should calculate the odds of dementia free sur-
vival, which would reduce survivorship bias.
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